SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety

SCHOTT Pharma, a leader in drug containment and delivery solutions, introduces the next generation of SCHOTT TOPPAC infuse polymer syringes, a system aimed at enhancing safety, efficiency, and sustainability in the healthcare sector. Created in collaboration with SCHOTT Pharma's Alliance to Zero partners, Schreiner MediPharm and Körber Pharma, the system includes a new cap, a functional label, and carton packaging.

This groundbreaking solution tackles essential issues hospitals encounter, such as excessive medication waste, ineffective manual procedures, and limitations in storage. It also enhances patient safety and the sustainability of the whole value chain.

"With our next-generation polymer syringe system, we are setting a new standard in the pharmaceutical industry by providing a solution that ensures drug stability, improves operational efficiency, and reduces precious drug and packaging waste," said Andreas Reisse, CEO of SCHOTT Pharma. "Our collaboration with Schreiner MediPharm and Körber Pharma has enabled us to create a product that truly meets the needs of our customers, healthcare providers, and patients alike."

The latest generation of SCHOTT TOPPAC polymer syringes will be showcased at the Pharmapack trade fair on January 22 – 23 in Paris, France. SCHOTT Pharma's advanced SCHOTT TOPPAC infuse prefillable polymer syringes aim to enhance hospital workflows from pre-op to inventory by decreasing manual preparation steps and reducing medication errors.